v3.25.2
Fair Value Measurements and Investments - Additional Information (Detail)
SFr in Millions, $ in Millions
Nov. 14, 2024
USD ($)
Nov. 14, 2024
CHF (SFr)
Oct. 01, 2020
USD ($)
Jun. 30, 2025
USD ($)
Oct. 01, 2020
CHF (SFr)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]          
Consideration transferred       $ 14.0  
Other Current Liabilities          
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]          
Consideration transferred       10.5  
Other long-term liabilities          
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]          
Consideration transferred       $ 3.5  
Neo Medical [Member]          
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]          
Convertible loans     $ 5.0   SFr 4.6
Sale of preferred equity securities $ 7.4 SFr 6.6      
Preferred Stock [Member] | Neo Medical [Member]          
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]          
Amount of Preferred stock consideration     $ 5.0